Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints

BackgroundIn adolescents limited data are available on the pharmacokinetics (PK) and pharmacodynamics (PD) of propofol. In this study we derived a PK-PD model for propofol in adolescents undergoing idiopathic scoliosis surgery with an intraoperative wake-up test with reinduction of anesthesia using both Bispectral Index (BIS) and composite A-line ARX index (cAAI) as endpoints.MethodsFourteen adolescents (9.8–20.1 years) were evaluated during standardized propofol-remifentanil anesthesia for idiopathic scoliosis surgery with an intraoperative wake-up test with reinduction of anesthesia. BIS and cAAI were continuously measured and blood samples collected. A propofol PKPD model was developed using NONMEM.ResultsThe time courses of propofol concentrations, BIS and cAAI values during anesthesia, intra-operative wakeup and reduction of anesthesia were best described by a two-compartment PK model linked to an inhibitory sigmoidal Emax PD model. For the sigmoidal Emax model, the propofol concentration at half maximum effect (EC50) was 3.51 and 2.14 mg/L and Hill coefficient 1.43 and 6.85 for BIS and cAAI, respectively. The delay in PD effect in relation to plasma concentration was best described by a two compartment effect-site model with a keo of 0.102 min− 1, ke12 of 0.121 min− 1 and ke21 of 0.172 min− 1.ConclusionsA population PKPD model for propofol in adolescents was developed that successfully described the time course of propofol concentration, BIS and cAAI in individuals upon undergoing scoliosis surgery with intraoperative wake-up test and reinduction of anesthesia. Large differences were demonstrated between both monitors. This may imply that BIS and cAAI measure fundamentally different endpoints in the brain.

[1]  H F Nicodemus,et al.  The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches , 1994, Anesthesiology.

[2]  A. Hoeft,et al.  The Performance of a Target-Controlled Infusion of Propofol in Combination with Remifentanil: A Clinical Investigation with Two Propofol Formulations , 2006, Anesthesia and analgesia.

[3]  M. Priston,et al.  Pharmacokinetics of Propofol Infusions in Critically Ill Neonates, Infants, and Children in an Intensive Care Unit , 2002, Anesthesiology.

[4]  Hugo Vereecke,et al.  An Evaluation of Using Population Pharmacokinetic Models to Estimate Pharmacodynamic Parameters for Propofol and Bispectral Index in Children , 2011, Anesthesiology.

[5]  Lewis B. Sheiner,et al.  Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.

[6]  I. Constant,et al.  Pharmacokinetic-Pharmacodynamic Modeling of Propofol in Children , 2010, Anesthesiology.

[7]  V. Deneer,et al.  Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[8]  C Jeleazcov,et al.  EEG variables as measures of arousal during propofol anaesthesia for general surgery in children: rational selection and age dependence. , 2007, British journal of anaesthesia.

[9]  France Mentré,et al.  Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R , 2008, Comput. Methods Programs Biomed..

[10]  Steven L Shafer,et al.  Influence of Administration Rate on Propofol Plasma–Effect Site Equilibration , 2007, Anesthesiology.

[11]  Byung-Moon Choi,et al.  Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children , 2015, Journal of Pharmacokinetics and Pharmacodynamics.

[12]  D. Tibboel,et al.  Propofol Pharmacokinetics and Pharmacodynamics for Depth of Sedation in Nonventilated Infants after Major Craniofacial Surgery , 2006, Anesthesiology.

[13]  Propofol Clearance in Morbidly Obese Children and Adolescents , 2012, Clinical Pharmacokinetics.

[14]  Anthony G. Doufas,et al.  Induction Speed Is Not a Determinant of Propofol Pharmacodynamics , 2004, Anesthesiology.

[15]  Mats O. Karlsson,et al.  A two-compartment effect site model describes the bispectral index after different rates of propofol infusion , 2010, Journal of Pharmacokinetics and Pharmacodynamics.

[16]  Nick Freemantle,et al.  Pharmacokinetics of a Single Bolus of Propofol in Chinese Children of Different Ages , 2006, Anesthesiology.

[17]  M. Danhof,et al.  Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients , 2011, Clinical pharmacokinetics.

[18]  R. Kaliszan,et al.  Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery , 2012, Pharmacological reports : PR.

[19]  Cockshott,et al.  Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.

[20]  T. Inge,et al.  Population pharmacokinetic–pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents , 2015, Paediatric anaesthesia.

[21]  Paweł Wiczling,et al.  Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery , 2015, Journal of Pharmacokinetics and Pharmacodynamics.

[22]  Erik Olofsen,et al.  Propofol Reduces Perioperative Remifentanil Requirements in a Synergistic Manner: Response Surface Modeling of Perioperative Remifentanil–Propofol Interactions , 2003, Anesthesiology.

[23]  Richard N Upton,et al.  A Physiologically Based, Recirculatory Model of the Kinetics and Dynamics of Propofol in Man , 2005, Anesthesiology.

[24]  R. Kaliszan,et al.  Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries , 2014, Pharmacological reports : PR.

[25]  Lewis B. Sheiner,et al.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine , 1979 .

[26]  C. Knibbe,et al.  PHARMACOKINETICS AND DISPOSITION , 2022 .

[27]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[28]  S. Shafer,et al.  Determination of the Pharmacodynamic Interaction of Propofol and Remifentanil during Esophagogastroduodenoscopy in Children , 2004, Anesthesiology.

[29]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[30]  J Schüttler,et al.  Population Pharmacokinetics of Propofol: A Multicenter Study , 2000, Anesthesiology.

[31]  J. DeJongh,et al.  Disease Severity Is a Major Determinant for the Pharmacodynamics of Propofol in Critically Ill Patients , 2008, Clinical pharmacology and therapeutics.

[32]  D. Tibboel,et al.  A Comparison in Adolescents of Composite Auditory Evoked Potential Index and Bispectral Index During Propofol-Remifentanil Anesthesia for Scoliosis Surgery with Intraoperative Wake-Up Test , 2008, Anesthesia and analgesia.

[33]  France Mentré,et al.  Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide , 2006, Pharmaceutical Research.